PAPER Arendash GW
SEARCH RESULTS
331254 RESULTS
PAPER Graff-Radford J, Boeve BF, Pedraza O, Ferman TJ, Przybelski S, Lesnick TG, Vemuri P, Senjem ML, Smith GE, Knopman DS, Lowe V, Jack CR, Petersen RC, Kantarci K
Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies.
Brain. 2012 Aug;135(Pt 8):2470-7. PubMed: 22810436PAPER Hernández-Ortega K, Arias C
ERK activation and expression of neuronal cell cycle markers in the hippocampus after entorhinal cortex lesion.
J Neurosci Res. 2012 Nov;90(11):2116-26. PubMed: 22811014PAPER Vadnal J, Houston S, Bhatta S, Freeman E, McDonough J
Transcriptional signatures mediated by acetylation overlap with early-stage Alzheimer's disease.
Exp Brain Res. 2012 Sep;221(3):287-97. PubMed: 22811216PAPER Yamaguchi T, Maki Y, Yamaguchi H
Yamaguchi Facial Expression-Making Task in Alzheimer's Disease: A Novel and Enjoyable Make-a-Face Game.
Dement Geriatr Cogn Dis Extra. 2012 Jan;2(1):248-57. PubMed: 22811688PAPER Fujita K, Yamafuji M, Nakabeppu Y, Noda M
Therapeutic approach to neurodegenerative diseases by medical gases: focusing on redox signaling and related antioxidant enzymes.
Oxid Med Cell Longev. 2012;2012:324256. PubMed: 22811764PAPER Chintamaneni M, Bhaskar M
Biomarkers in Alzheimer's disease: a review.
ISRN Pharmacol. 2012;2012:984786. PubMed: 22811931PAPER Rong XF, Wang XL
[An overview of biomarkers in Alzheimer's disease].
Yao Xue Xue Bao. 2012 May;47(5):551-7. PubMed: 22811995PAPER Zhou L, Gan CS, Wang HS, Zhao ZZ, Pan J
[Synthesis of benzothiazole derivatives and their binding characteristics with beta-amyloid].
Yao Xue Xue Bao. 2012 May;47(5):685-8. PubMed: 22812018PAPER Nakamura Y
[New anti-AD drugs--their possibilities and issues].
Seishin Shinkeigaku Zasshi. 2012;114(3):255-61. PubMed: 22568059PAPER Richard E, Schmand B, Eikelenboom P, Westendorp RG, Van Gool WA
The Alzheimer myth and biomarker research in dementia.
J Alzheimers Dis. 2012;31 Suppl:S203-9. PubMed: 22810091PAPER Yeaman PA, Ford JL, Kim KY
Providing Quality Palliative Care in End-Stage Alzheimer Disease.
Am J Hosp Palliat Care. 2012 Jul 18; PubMed: 22811214Gerhard Koenig on Novel Drug Knocks Aβ Off Synapses, Reduces Toxicity
COMMENT This is an interesting paper and follows the initial findings of Wang et al., 2000 (same first author), where it was shown that Aβ42 has a very high-affinity interaction with the α7 nicotinic acetylcholine receptor. The intracerebrovascular infusion of Aβ
Peter Vandenabeele on Amyloid Fibrils as Signaling Complexes? Role in Cell Death Pathway
COMMENT Amyloid aggregation in programmed necrosis or necroptosis Our lab was one of the first describing necrotic cell death as a programmed form of cell death implicated in many inflammatory and degenerative pathologies (Vandenabeele et al., 2010). Until recent
Peter Vandenabeele
VIB, Ghent UniversityGhent, Belgium
Current Filters
No filters selected